---
title: Grifols Partnership vs Rotop Pharmaka GmbH
slug_a: grifols
slug_b: rotop-pharmaka
site: cdmo
review_signal_gate: closed
canonical_path: /compare/grifols/rotop-pharmaka
---

# Grifols Partnership vs Rotop Pharmaka GmbH

Side-by-side profile data from each company listing on this directory.

## Grifols Partnership

- Profile: [/companies/grifols](/companies/grifols)

Grifols Partnership — CDMO specializing in small molecule injectable products, including concentrated and diluted parenteral formulations and intravenous solutions, leveraging 100+ years of Grifols expertise.

Services: 10. Modalities: 2. Indications: 5. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (10).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Biologics (Other)

### Development capabilities

- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials

## Rotop Pharmaka GmbH

- Profile: [/companies/rotop-pharmaka](/companies/rotop-pharmaka)

Rotop Pharmaka GmbH — ROTOP Pharmaka GmbH is a Dresden-based radiopharmaceutical manufacturer offering end-to-end CDMO services for radiopharmaceuticals, from early-stage development to commercial supply.

Services: 11. Modalities: 1. Indications: 3. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- API Synthesis & Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Lyophilization (Freeze Drying)
- Process Development
- Formulation Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Radiopharmaceutical

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials